Post by
geodcan on May 30, 2024 7:16pm
I listened to the Klein BNN interview
and took notice that there were attempts to get straight answers on the goings on in the Canopy camp.
I also noticed Klein's coy responses about making the understanding part of how this great merger/takeover/amalgamation of all of these parts in to CUSA is going to shake out.
I never picked up on any mention of the destruction done to Canopy and Acreage shareholders that were inflicted with the 1 for 10 consolidation that gutted long term shareholders since STZ took an interest in the cannabinoid business with their huge investment in Canopy and vicariously through the deal between Canopy and Acreage.
The kind of deals activated by STZ and under their influence are complex, difficult to understand and have future pitfalls for success and failure, depending on which way the market thinks the wind is blowing.
The latest financial might as well have been written in some foreign language, as far as I am concerned, because I found it ambiguous by intention to really be able to discern if it is good or bad for shareholders.
I daresay that it looks like Klein is going to try to ressurect this from the huge pile of ashes that has been left by their administration since about the time that they took a controlling interest in Canopy and associates.
I would suggest that Canopy's decline was as much by design as normal market influences but have a difficult time argueing that most potpreneurs were way overpriced and due for a correction.
I had huge issue with the BioSteel deal that was the darling one day and shyt on a stick the next day. Somebody mentioned that Canopy kept the manufacturing facility for future use and was pleased that Klein made mention of cannabinoid beverage skus and that they are still in the future plans.
Forward progress is still being stymied by the lack of the politicians involved getting a push on to pave the way for success of this promising new vice and pharmaceutical option.
The politicians have done a lot of good pot bills that need to be put in to law and I can't ignore the SAFE bill that could become a Federal legalization bill that will defineately help to aid and assist investments in to the new vice through regular banking channels that are available to every other legal business in the US, except the marijuana companies.
I wouldn't want to be the politician who's name is associated with Federal legalization which will incur some wrath from the black market.
The outcome for legalization is pretty good but having the laws in place would quicken and support a US greenrush, or it could just trickle along one State at a time and lose that huge moneymaking potential that Canada's legalization effort triggered. Huge potential for huge profits for smart investors.
I don't know if Canopy et al under the influence of STZ has smeared the potential beyond recovery for those of us who are underwater.
That shouldn't be the case but that consolidation of shares was a huge detriment to investor enthusiasm that could choose to ignore that Canopy is now a lean and mean venture, set up for success, to the degree it once had.
glta and dyodd
Comment by
Matteo1234 on May 31, 2024 6:01am
Pappi. bottom line is he said its a new industry still. CGC is a growth stock. Disruptive to the medical industry. Hold long term. I believe the drawdown was manufactured to shave the hamsters. Stayhard
Comment by
BrokerG on May 31, 2024 10:08am
I think you may be right Newbie. We are currently trading below the quarterly release. What happened?. Was the release positive or not? I am going to love to hear Q's explanation for this one.